CONRAD has designed and conducted over 115 Phase I, II and III studies since its inception using almost 40 different contraceptive and/or microbicidal products, devices, agents and formulations. CONRAD’s clinical and regulatory staff have filed and managed multiple Investigational New Drug applications (INDs) and Investigational Device Exemptions (IDEs), and related amendments. 

View our Clinical Studies for more details.